4
Journals
65K
Articles
5.7M
Citations
16.4K
Authors

Most Cited Articles of Angiology in 2021

TitleJournalYearCitations
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart AssociationCirculation20211.1K
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation2021239
Myocarditis With COVID-19 mRNA VaccinesCirculation2021218
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation2021170
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic OptionsCirculation2021130
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in EuropeCirculation2021115
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2Circulation Research2021114
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationCirculation2021112
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease RegistryCirculation2021108
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in ChildrenCirculation202197
Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic StudyCirculation202194
Myocarditis Temporally Associated With COVID-19 VaccinationCirculation202188
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Circulation202185
Myocarditis After BNT162b2 and mRNA-1273 VaccinationCirculation202181
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced TrialCirculation202180
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 DiabetesCirculation202176
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialCirculation202174
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled TrialCirculation202173
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HFCirculation202169
COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR)Circulation202169
Cardiac Energy Metabolism in Heart FailureCirculation Research202168
Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial CellsCirculation202167
COVID-19-Associated Nonocclusive Fibrin Microthrombi in the HeartCirculation202164
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in WomenCirculation202161
Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEFCirculation Research202158